These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20348495)

  • 41. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.
    Lumb V; Das MK; Singh N; Dev V; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5173-80. PubMed ID: 19786603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
    Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
    Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
    Malisa AL; Pearce RJ; Mutayoba BM; Abdullah S; Mshinda H; Kachur PS; Bloland P; Roper C
    Malar J; 2011 Oct; 10():317. PubMed ID: 22029848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
    Bwire GM; Mikomangwa WP; Kilonzi M
    BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study.
    Biswas S; Escalante A; Chaiyaroj S; Angkasekwinai P; Lal AA
    Trop Med Int Health; 2000 Oct; 5(10):737-43. PubMed ID: 11044269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of putative drug resistant biomarkers in Plasmodium falciparum isolated from Ghanaian blood donors.
    Aninagyei E; Duedu KO; Rufai T; Tetteh CD; Chandi MG; Ampomah P; Acheampong DO
    BMC Infect Dis; 2020 Jul; 20(1):533. PubMed ID: 32698879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
    McCollum AM; Mueller K; Villegas L; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2085-91. PubMed ID: 17283199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
    Méndez F; Muñoz A; Carrasquilla G; Jurado D; Arévalo-Herrera M; Cortese JF; Plowe CV
    Am J Epidemiol; 2002 Aug; 156(3):230-8. PubMed ID: 12142257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.
    Certain LK; Briceño M; Kiara SM; Nzila AM; Watkins WM; Sibley CH
    J Infect Dis; 2008 Jun; 197(12):1743-51. PubMed ID: 18513156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy.
    Abdul-Ghani R; Farag HF; Allam AF; Shawky SM
    Acta Trop; 2014 Apr; 132():39-44. PubMed ID: 24406851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
    Kar NP; Chauhan K; Nanda N; Kumar A; Carlton JM; Das A
    Infect Genet Evol; 2016 Jul; 41():47-55. PubMed ID: 26988711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes.
    Mharakurwa S; Kumwenda T; Mkulama MA; Musapa M; Chishimba S; Shiff CJ; Sullivan DJ; Thuma PE; Liu K; Agre P
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18796-801. PubMed ID: 22065788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in Haiti.
    Carter TE; Warner M; Mulligan CJ; Existe A; Victor YS; Memnon G; Boncy J; Oscar R; Fukuda MM; Okech BA
    Malar J; 2012 Aug; 11():275. PubMed ID: 22889367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.